1. Home
  2. ATEN vs ELVN Comparison

ATEN vs ELVN Comparison

Compare ATEN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEN
  • ELVN
  • Stock Information
  • Founded
  • ATEN 2004
  • ELVN 2016
  • Country
  • ATEN United States
  • ELVN United States
  • Employees
  • ATEN N/A
  • ELVN N/A
  • Industry
  • ATEN EDP Services
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATEN Technology
  • ELVN Health Care
  • Exchange
  • ATEN Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • ATEN 1.2B
  • ELVN 1.1B
  • IPO Year
  • ATEN 2014
  • ELVN 2020
  • Fundamental
  • Price
  • ATEN $19.01
  • ELVN $24.24
  • Analyst Decision
  • ATEN Strong Buy
  • ELVN Strong Buy
  • Analyst Count
  • ATEN 2
  • ELVN 5
  • Target Price
  • ATEN $20.00
  • ELVN $37.80
  • AVG Volume (30 Days)
  • ATEN 708.4K
  • ELVN 164.8K
  • Earning Date
  • ATEN 02-04-2025
  • ELVN 11-13-2024
  • Dividend Yield
  • ATEN 1.26%
  • ELVN N/A
  • EPS Growth
  • ATEN 26.31
  • ELVN N/A
  • EPS
  • ATEN 0.66
  • ELVN N/A
  • Revenue
  • ATEN $257,909,000.00
  • ELVN N/A
  • Revenue This Year
  • ATEN $5.09
  • ELVN N/A
  • Revenue Next Year
  • ATEN $7.81
  • ELVN N/A
  • P/E Ratio
  • ATEN $28.74
  • ELVN N/A
  • Revenue Growth
  • ATEN N/A
  • ELVN N/A
  • 52 Week Low
  • ATEN $12.27
  • ELVN $10.90
  • 52 Week High
  • ATEN $19.37
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • ATEN 75.72
  • ELVN 46.10
  • Support Level
  • ATEN $16.78
  • ELVN $22.92
  • Resistance Level
  • ATEN $19.37
  • ELVN $24.42
  • Average True Range (ATR)
  • ATEN 0.47
  • ELVN 1.46
  • MACD
  • ATEN 0.05
  • ELVN 0.08
  • Stochastic Oscillator
  • ATEN 90.73
  • ELVN 56.56

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of secure application solutions and services that enables a new generation of intelligently connected companies, the ability to continuously improve cyber protection and digital responsiveness across dynamic Information Technology and network infrastructures. Its portfolio consists of six secure application solutions; Thunder Application Delivery Controller, Lightning Application Delivery Controller, Thunder Carrier Grade Networking, Thunder Threat Protection System, Thunder SSL Insight and Thunder Convergent Firewall, and two intelligent management and automation tools; Harmony Controller and aGalaxy TPS. Key revenue is generated from the Americas, with the rest coming from Europe, the Middle East and Africa, plus the Asia Pacific region.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: